반응식
[CH2:1]([S:3][C:4]1[N:9]([CH3:10])[C:8](=[O:11])[N:7]([CH3:12])[C:6](=[O:13])[C:5]=1[CH:14]=O)[CH3:2].Cl.[CH3:17][O:18][NH2:19]>>[CH3:17][O:18][N:19]=[CH:14][C:5]1[C:6](=[O:13])[N:7]([CH3:12])[C:8](=[O:11])[N:9]([CH3:10])[C:4]=1[S:3][CH2:1][CH3:2]참가 물질
3
실험 절차
The process described in Method A was followed. 6-(Ethylthio)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde (Example 23, Step 1) (0.148 mg, 0.65 mmol) and methoxyamine hydrochloride (0.072 mg, 0.86 mmol) were used to obtain the title compound.
출처 및 근거
- ORD 기록
- ord-a29887dc0aff492ba169e4328b29485c
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08536210B2
연결된 노트
불러오는 중…